OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Obsidian Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$11.94+0.17 (+1.44%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
2 of Obsidian Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 3, 2026 | SEC EDGAR |